Signal AI agents in early drug discovery raised wet lab capacity 21 to 30 percent at one company
Summary
McKinsey reports that integrating AI agents into research and early drug discovery workflows produced a 21 to 30 percent improvement in wet lab capacity at one pharmaceutical company, speeding candidate drugs toward trials.
Classification
Main topicBio & Health Tech
Region menusGlobal
Impactscope:global
Time horizon0-3 years (2026-07-26)
Last updated2026-07-29 04:49:52
Evidence 1
- The State of Organizations 2026 McKinsey & Company page=18;section=Technology disruption: Humans and AI agents - Building a new world of collaboration / Benefits of getting it right 2026-02 accessed 2026-07-26
Part of trends 1
Directly linked issues 0
No objects.
Relation types: supports
Public id: fm-e8a0eabb6df0